DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  ☒                              Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under §240.14a-12

Brinker International, Inc.

(Name of Registrant as Specified In Its Charter)

 

    

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 


LOGO

 

  P.O. BOX 8016, CARY, NC 27512-9903

  

Brinker International, Inc.

Important Notice Regarding the Availability

of Proxy Materials

 

Shareholders Meeting to be held on

November 17, 2022

   For Shareholders of record as of September 19, 2022
   This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.
  

To view the proxy materials, and to obtain directions to attend the meeting, go to: www.proxydocs.com/EAT

 

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

   Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.

 

        

 

 
LOGO  

For a convenient way to view proxy materials and VOTE go to

www.proxydocs.com/EAT

 

Have the 12 digit control number located in the shaded box above available

when you access the website and follow the instructions.

 

  LOGO
  If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before November 07, 2022.  
  To order paper materials, use one of the following methods.  

 

LOGO

 

INTERNET

www.investorelections.com/EAT

    

 

LOGO     

 

TELEPHONE    

(866) 648-8133    

   

LOGO

 

* E-MAIL

paper@investorelections.com

             
   
                  

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above.

    * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.

 

Brinker International, Inc.

Meeting Type:   Annual Meeting of Shareholders

     Date:

Thursday, November 17, 2022

     Time:

9:00 AM, Central Standard Time

     Place:

A live webcast of the Annual Meeting will be

available online at www.proxydocs.com/EAT

To attend the meeting and participate visit www.proxydocs.com/EAT

SEE REVERSE FOR FULL AGENDA


Brinker International, Inc.

Annual Meeting of Shareholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

 FOR ON PROPOSALS 1, 2, 3 AND 4

 AGAINST ON PROPOSAL 5

PROPOSAL

 

1.

Election of Directors

1.01 Joseph M. DePinto

1.02 Frances L. Allen

1.03 Cynthia L. Davis

1.04 Harriet Edelman

1.05 William T. Giles

1.06 Kevin D. Hochman

1.07 Ramona T. Hood

1.08 James C. Katzman

1.09 Prashant N. Ranade

 

2.

Ratification of the appointment of KPMG LLP as our Independent Registered Public AccountingFirm for the fiscal year 2023.

 

3.

Advisory Vote to Approve Executive Compensation.

 

4.

Amendment of Company’s 1999 Stock Option and Incentive Plan.

 

5.

Shareholder Proposal Requesting Report on Measures Company is Taking to End the Use of Medically Important Antibiotics in the Company’s Meat and Poultry Supply.